Navigation Links
Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
Date:1/4/2011

PRINCETON, N.J., Jan. 4, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the 29th Annual J.P. Morgan Healthcare Conference to be held January 10-13, 2011 at the Westin St. Francis Hotel, San Francisco, CA. Schaefer Price, President and Chief Executive Officer, will provide an overview of the company on Wednesday, January 12, 2011 at 9:00 AM (PT).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About PharmassetPharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (HCV). Our research and development efforts focus on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. We currently have four clinical-stage product candidates. RG7128, a cytosine nucleoside analog for chronic HCV infection, is in tw
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Decision Resources Group finds that the Asia Pacific ... China , India , Japan ... 2023. Dental implant procedure volumes will grow as physicians are increasingly ... Other key findings from Decision Resources Group,s coverage of the ... , Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... 2014 According to ... by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments ... Application (Immunology, Oncology) & by End User ... MarketsandMarkets, provides a detailed overview of the ... trends, and strategies impacting the global glycomics ...
(Date:9/30/2014)...   Easy Breathe , the fastest growing online ... it now offers the revolutionary AirSense CPAPs ... sleep apnea therapy devices with internal cellular modems.  This ... and share real-time data on each user,s quality of ... In addition, the internal modem allows the CPAP to ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4
... be treated with nephron-sparing approaches when possibleLINTHICUM, Md., ... the affected kidney) is not the best treatment ... patients at risk for chronic kidney disease and ... nephrectomy, thermal ablation and active surveillance, minimize these ...
... Pomegranate juice may slow the progression ... long-term research results being presented at the 104th ... (AUA). Researchers found that men who have undergone ... drinking pomegranate juice. The two-stage clinical trial ...
Cached Medicine Technology:AUA Guideline: Full Kidney Removal Not Necessary for All Kidney Tumors 2AUA Guideline: Full Kidney Removal Not Necessary for All Kidney Tumors 3Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption 2
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog ... couples. , Senior citizens can purchase a joint ... loved ones. A joint policy is cheaper, but will ... , Life insurance can be used to cover ... be purchased online, as the application process is simple ...
(Date:10/1/2014)... 2014 Lifeinsurance-policy.com has released a ... life insurance prices for smokers. , Smoking will always ... Comparing quotes is the best method to find affordable ... customers who need coverage. , Whole life insurance ... the policy. Since the coverage is permanent, the initial ...
(Date:10/1/2014)... WASHINGTON, D.C. and ATLANTA (PRWEB) October 01, ... and information security executive networking and relationship-marketing ... the 2014 Information Security Executive® and Project ... Executives include top-ranking decision makers representing organizations ... and academics. Projects include large-scale technology endeavors ...
(Date:10/1/2014)... N.C. A new genetic finding from Duke Medicine ... anxiety and depression might also be hard-wired to gain ... and heart disease. , An estimated 13 percent of ... genetic susceptibility, and knowing this could help them reduce ... diet, exercise and stress management. , "Genetic susceptibility, psychosocial ...
(Date:10/1/2014)... 2014 Innovations announces the upcoming airing ... on Monday, October 20, 2014 at 7:30 a.m. EST/PT ... go behind the scenes to learn about Break the ... explore the practical help and information Break the Cycle ... warning signs of abuse, how to navigate the legal ...
Breaking Medicine News(10 mins):Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... studies examine the use of the nucleoside polymerase inhibitor, ... reports appear in the August issue of Hepatology ... on behalf of the American Association for the Study ... at Wiley Interscience ( www.interscience.wiley.com ). , The ...
... scientists are attempting to recognize and treat schizophrenic disorders ... will improve the prognosis, which has often been unfavorable. ... ( Dtsch Arztebl Int 2008; 105[30]: 532-9), ... at Cologne University describes the current state of research ...
... Offer Groundbreaking The Prevention Plan to Employers, ... Medicine,( http://www.USPreventiveMedicine.com ), the leader in disease ... they have formed a,strategic alliance that will ... offer U.S. Preventive Medicine,s groundbreaking prevention program ...
... best-of-breed security deployment helps protect Verispan,s HIPAA-compliant, de-identified, patient-centric market ... ... Reston, VA and Ottawa, ON (PRWEB) ... security software company specializing in host intrusion defense, today announced ...
... Attila Molnar ... 31 The Management Board of Bayer AG,announced today that ... the Senior Bayer Representative in North America,succeeding Dr. Attila Molnar, ... effective October 1, 2008. Bayer Corporation is the U.S.,subsidiary of ...
... In Recognition of World,Breastfeeding Week, Mary Ann ... online access to Breastfeeding Medicine, (http://www.liebertpub.com/bfm ) ... a MEDLINE journal, the official publication of ... peer-reviewed medical journal,providing physicians with the evidence-based ...
Cached Medicine News:Health News:New treatment therapy helps inhibit hepatitis C 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 3Health News:Verispan Calls on Third Brigade for Added Data Protection 2Health News:Verispan Calls on Third Brigade for Added Data Protection 3Health News:Photos: Bayer Names New U.S. CEO 2Health News:Photos: Bayer Names New U.S. CEO 3Health News:Photos: Bayer Names New U.S. CEO 4Health News:Mary Ann Liebert, Inc. Provides Complimentary Online Access to Breastfeeding Medicine for the Month of August 2
... Renu Multiplus no rub formula is ... available today. All steps in one bottle ... disinfects, stores your soft contact lenses and ... the only multi-purpose solution that contains Hydranate, ...
Children's Half Trial Frames...
... comes at a very attractive price. ,The following adjustments can ... 4 1/8" to 5 1/2" (98 to 135mm), Nose ... PD adjustable 24 to 40mm on each side (48mm to ... left - 120 to 0 to 135 , right - ...
... Sterile Bad-Parker blades offer the superior ... steel technology, plus the exclusive Rib-Back ... strength. Brad-Parker brand producer offer the ... and disposable scalpels. Every blade is ...
Medicine Products: